PIGC

Chr 1AR

phosphatidylinositol glycan anchor biosynthesis class C

Also known as: GPI2, GPIBD16, MRT62

This gene encodes an endoplasmic reticulum associated protein that is involved in glycosylphosphatidylinositol (GPI) lipid anchor biosynthesis. The GPI lipid anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. The encoded protein is one subunit of the GPI N-acetylglucosaminyl (GlcNAc) transferase that transfers GlcNAc to phosphatidylinositol (PI) on the cytoplasmic side of the endoplasmic reticulum. Two alternatively spliced transcripts that encode the same protein have been found for this gene. A pseudogene on chromosome 11 has also been characterized. [provided by RefSeq, Jul 2008]

OMIMResearchGenerating clinical summary…
DNmechanismARLOEUF 1.061 OMIM phenotype
Clinical SummaryPIGC
🧬
Gene-Disease Validity (ClinGen)
glycosylphosphatidylinositol biosynthesis defect 16 · ARLimited

Limited evidence — not for standalone diagnostic reporting

Population Constraint (gnomAD)
Low constraint (pLI 0.01) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
7 unique Pathogenic / Likely Pathogenic· 59 VUS of 87 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.06LOEUF
pLI 0.006
Z-score 1.46
OE 0.50 (0.261.06)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.79Z-score
OE missense 0.83 (0.720.95)
137 obs / 165.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.50 (0.261.06)
00.351.4
Missense OE?0.83 (0.720.95)
00.61.4
Synonymous OE?0.63
01.21.6
LoF obs/exp: 5 / 10.0Missense obs/exp: 137 / 165.5Syn Z: 2.34

This gene — mechanism propensity

DN
0.6840th %ile
GOF
0.5857th %ile
LOF
0.2970th %ile

The highest-scoring mechanism for this gene is dominant-negative.

DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

87 submitted variants in ClinVar

Classification Summary

Pathogenic4
Likely Pathogenic3
VUS59
Likely Benign13
Benign5
Conflicting2
4
Pathogenic
3
Likely Pathogenic
59
VUS
13
Likely Benign
5
Benign
2
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
2
0
0
4
Likely Pathogenic
1
2
0
0
3
VUS
2
56
1
0
59
Likely Benign
0
1
1
11
13
Benign
0
2
0
3
5
Conflicting
2
Total56321486

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

27 pathogenic / likely-pathogenic (of 32) ClinVar copy-number / structural variants overlap PIGC — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PIGC · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →